Inmed announces appointment of chief operating officer

Vancouver, british columbia, july 18, 2022 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announces michael woudenberg has been appointed chief operating officer of the company, overseeing all day-to-day operations.

INM Ratings Summary

INM Quant Ranking